市場調查報告書
商品編碼
1226695
顯影劑注射套組的全球市場:現狀分析與預測(2022年~2028年)Contrast Media Injection Sets Market: Current Analysis and Forecast (2022-2028) |
全球顯影劑注射套組的市場規模,預計2022年~2028年之間記錄約5%的年複合成長率。癌症的盛行率增加和診斷方法增加,以及,心臟,肺,骨,腦等各種疾病診斷中使用核子醫學攝影檢驗,成為市場成長的原動力。可是,注射套組的高成本和受訓練的專家不足等,妨礙在全球這個市場的成長。
本報告提供全球顯影劑注射套組市場相關調查分析,市場概要,各市場區隔、各地區的市場分析,市場成長的影響因素,市場趨勢,競爭情形,主要企業簡介等彙整資訊。
The contrast media injection sets market is expected to register a CAGR of approx. 5% over the period of 2022-2028. Contrast media administration sets, or injection sets are made to regulate the number of contrast agents that are actually supplied to an administration system (such as an injector) in order to prevent waste and regulate the total amount of contrast agents used for a single procedure. When performing various imaging tests like computed tomography (CT), magnetic resonance imaging (MRI), radiography, and occasionally ultrasound imaging, contrast media are used to increase the contrast of bodily fluids for better imaging. With the aid of contrast media, blood vessels can be seen, allowing for the examination of the spine, kidneys, and internal organs of the brain. Contrast media aids in the differentiation of different body parts with similar compositions, and thus, contrast media. The growing demand for contrast media injection sets can be attributed to the increasing prevalence of cancer across the globe. For instance, according to the World Health Organization, Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. In 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States. Owing to the glaring statistics the rising prevalence of cancer leads to higher demand for contrast media injection which boosts the demand for contrast media injection sets across the globe and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the contrast media injection sets market is anticipated to grow on account of the increasing number of diagnostic procedures. In addition, increasing usage of nuclear imaging tests for the diagnosis of various conditions related to the heart, lungs, bones, brain, and other systems drives the market growth. However, some of the restraints in the market including the high cost of injection sets and lack of trained professionals are impeding the growth of this market all over the world.
Based on the product, the contrast media injection sets market is segmented into contrast media injection sets with a bore vented tubing, contrast media injection sets with a vented bifurcated standard bore, contrast media injection sets with a vented pressurized spike, and others. The contrast media injection sets with a bore vented tubing segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe. Professionals frequently use these products because they are simple to use and more widely available than other product categories.
Based on the end-user, the market is fragmented into hospitals, cancer research institutes, diagnostic imaging centers, and others. The diagnostic imaging centers segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. Increased procedure volume, combined with patient convenience, and a lack of imaging modalities in small and medium-sized hospitals are boosting segment growth. In order to improve ease of use and create products that can help control the waste of contrast agents, manufacturers of contrast media injection sets are concentrating on creating more innovative sets.
For a better understanding of the market adoption of the contrast media injection sets, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the contrast media injection sets industry owing to increased nuclear imaging procedures and the availability of high-end products. Moreover, the presence of well-established healthcare facilities, growing advanced technologies, as well as rising healthcare spending boost the market growth in this region.
Some of the major players operating in Bayer AG; ulrich GmbH & Co. KG; Medtron AG; ICU Medical, Inc; B. Braun SE; Apollo Rt Co. Ltd; Nemoto Kyorindo Co. Ltd; Guerbet Group; GE Healthcare; Shenzhen Anke High-tech Co. Ltd among others. Several M&A's along with partnerships have been undertaken.